chrisvoncsefalvay/vaers-outcomes huggingface dataset:
25 minutes post vaccine community member stated that her throat felt scratchy, has a history of environmental allergies and history of anaphylaxis during allergy shot testing and was given EPI. CG took her albuterol inhaler and was given 25 mg of PO Benadryl. Monitored for approx. 1 hour post vaccine. stated that scratchy throat was gone and was driven home by family member.
Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant products were not provided.  Reporter states that because their facility has not been able to download the digital data logger, they have been put on hold by the local Health Authority at the moment and cannot administer the Moderna COVID-19 vaccine to patients until an assessment by the local Health Authority is made. There have been no power outages that would have impacted the Moderna vaccine. However, she reiterates that because her facility is unable to download the digital data logger, they will need to treat this issue as a temperature excursion. The data logger that caller is unable to download are for the months of DEC2021, JAN2022, and FEB2022. She says that they are filling out a temperature excursion assessment with the local Health Authority at this time. Patients have been administered doses while the temperature excursion assessment has been ongoing.  No adverse reactions were reported by any patients.  Treatment medications were not reported.
Information has been received from a consumer and a physician concerning a 5 day old male patient who on 18-OCT-2010 was vaccinated with a dose of GARDASIL (lot # unknown). Father's consumer stated that on 18-OCT-2010 the patient received inadvertently an unspecified dose of GARDASIL (lot # unknown) when he should have received vaccination for hepatitis b. The physician stated that the patient inadvertently received an unspecified dose of GARDASIL by an unspecified route at an unspecified, different pediatrician's office. No adverse effect was reported by the physician. Follow up information has been received from the physician who stated that the now 3 week old patient with not illness at the time of vaccination, no preexisting allergies, birth defects and medical condition was vaccinated on 18-OCT-2010 in the morning (time not specified) intramuscularly with a dose of GARDASIL (Lot # 666597/0768Z). No adverse events were reported. Follow-up information has been received from the physician who stated that the patient was vaccinated with a dose of GARDASIL (lot # 666948/0886Z, reported before as Lot # 666597/0768Z). No further information is available.
Pt recv vax on 3/3/99; on 3/4/99 pt exp induration of left upper arm
This spontaneous report as received from a registered nurse refers to a 21 month old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 18-APR-2017, the patient was vaccinated with the improperly stored (between 6 and 14 degrees Fahrenheit for 30 minutes) dose of VARIVAX (for prophylaxis, lot # L050561 with expiration date of 14-DEC-2017 or lot # M019841 with expiration date of 20-APR-2018; dose and route of administration were not reported) that was reconstituted with the properly stored sterile diluent. No adverse effects and no previous temperature excursion were reported. Data logger was involved. This is one of several reports received from the same source. Additional information has been requested.; Sender's Comments: US-009507513-1704USA009837:
Mother came to vaccine clinic with child.  Requested 2nd dose of Moderna Infant/Toddler vaccine and second Influenza vaccine.  Vaccine card showed previous Moderna vaccine given 10/5/2022.  Vaccines given.  When documenting, noted that a prior dose of Influenza vaccine was given 9-14-2022 in  provider office.
Information has been received from a consumer, who is the mother of the patient, for the pregnancy registry for GARDASIL concerning an 18 year old female who sometime last year (2007) was vaccinated with the first dose of GARDASIL (lot# not reported). Per the reporter, the patient received the second dose of GARDASIL (lot # not reported) either in November or December 2007. About a week ago, the patient found out that she was pregnant (gestation = "patient is 3 months pregnant") and her due date is on 27-OCT-2008 (LMP is approximately 19-JAN-2008). The patient sought unspecified medical attention. About a week ago the patient had a positive urine pregnancy test. No further AE information was provided. Follow-up information was received from a physician concerning the patient with no known allergies and a history of epilepsy, loop electrosurgical excision procedure in Aug 2007 and gastroesophageal reflux disease who at 06:06 on 05-NOV-2008, delivered a normal male infant with no congenital anomalies. It was reported that patient's prenatal testing included ultrasound which was performed on 30-MAY_2008, 05-AUG-2008 and 25-SEP-2008, and her estimated delivery date was 01-DEC-2008. The patient's medication used during pregnancy included prenatal vitamins, prilosec, 20 mg for gastroesophageal reflux disease and Zetran 4 mg for nausea. It was reported that the patient experienced mild pre-eclampsia since 14:23 28-OCT-2008, and severe pre-eclampsia since 13:46 30-OCT-2008. Vacuum assisted delivery was done for problematic fetal heart rate pattern (deep recurrent variables to 100 returning to baseline with overshoots. Minimal progress with pushing from +2 station). Apgar scores included: apgar 1 min: 6; apgar 5 min: 7. The outcome of birth infant included: weight: 2845 gm (6lbs + 4.354 oz) length: 49.50 cm (19.5 inches), head circumference: 34.50 cm (13.6 inches), chest circumference: 32.50 cm (12.8 inches). Additional information has been requested.
This spontaneous report as received from a female consumer of unknown age and another consumer refers to the first reporter. The patient stated that she did have pain which was present prior to vaccination. She would have pain whenever she ate specific foods since 1976 (reported as for 40 years or so). On an unknown date the patient received a dose of ZOSTAVAX (dose, strength, route, lot # and expiration date were not reported). Concomitant drug was not reported. At unspecified time, the customer was seated waiting to pay for the vaccine when she reported loss of consciousness. The patient's husband stated the time for passing out was two or three minutes (it was also reported by the second reporter that it was approximately 30 seconds). The patient stated that she never said she experienced abdominal pain as a result of the vaccine (it was also reported by the second reporter that the patient had abdominal pain). The causality was not reported. Additional information has been requested.
A few hours after injection, arm muscle started to hurt and it has never improved, I have used heat, muscle rubs, and pain relievers.  It has been 6 weeks now with no improvement, Difficult to use that arm for many tasks
19JAN93 11AM pt vax & 115PM mom called stated pt eyes swollen -face; referred to ER-face & eyes orbital swollen; t97.6 & eczema rash face & turnk;
Extreme chest pain; Couldn't breathe; sore throat; Loss of sense of taste; Fatigue; Headache; Agitated asthma symptoms; This spontaneous case was reported by a consumer and describes the occurrence of ASTHMA (Agitated asthma symptoms), CHEST PAIN (Extreme chest pain), DYSPNOEA (Couldn't breathe), OROPHARYNGEAL PAIN (sore throat) and AGEUSIA (Loss of sense of taste) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, the patient experienced ASTHMA (Agitated asthma symptoms). On 26-Mar-2021, the patient experienced CHEST PAIN (Extreme chest pain), DYSPNOEA (Couldn't breathe), OROPHARYNGEAL PAIN (sore throat), AGEUSIA (Loss of sense of taste), FATIGUE (Fatigue) and HEADACHE (Headache). At the time of the report, ASTHMA (Agitated asthma symptoms), CHEST PAIN (Extreme chest pain), DYSPNOEA (Couldn't breathe), OROPHARYNGEAL PAIN (sore throat), AGEUSIA (Loss of sense of taste), FATIGUE (Fatigue) and HEADACHE (Headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, COVID-19: Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not reported. Treatment details provided include maintenance inhaler
Had a pre-op EKG a week following vaccine. Have never had heart issues or an abnormal EKG previously. This time the EKG came back as abnormal. Surgery is for scar revision related to previous mastectomy.
Information has been received from a medical assistant concerning a female patient at another physician's office who was vaccinated with a dose of GARDASIL and experienced at the injection site of being hot, swollen and hurt during first couple of days and then the area hardened for 2 weeks. Additional information is not expected.
Left-sided back pain started 2/6 and occurred intermittently.  On 2/15, the back pain worsened and I developed  gross hematuria, urinary urgency and frequency. On 2/17, I had a KUB series which showed a left distal ureteral stone. On 2/18, I passed a 3 mm kidney stone. I have no prior history of nephrolithiasis. There were no recent changes in diet or fluid intake.
12/15/2020 little bit of a headache at night and took an ibuprofen, intermittent nausea the next day, around 530 pm 12/16/2020 fatigue joint pain chills, I had a fever but I did not take my temp, nausea at 9pm I took ibuprofen and this morning 12/17/2020 I woke up fine.
IMMUNIZATIONS GIVEN IN LEFT DELTOID, PATIENT REPORTS FEVER 24 HOURS AFTER VACCINE GIVEN,LEFT DELTOID ALSO WITH VISABLE HIVES
Patient reported that the day he received his first Moderna COVID 19 vaccine, he did his glatiramer injection in the evening, and he experienced hives and flushing. Two glatiramer injections later (about 4 days later), he experienced hives and flushing with significant chest tightness and dizziness that caused him to go to the ER.
Swollen, warm to touch, hardened, painful mass 4 cm x 4 cm at the site of injection on left upper arm.
Patient reported an outbreak of shingles after 1st dose of SHINGRIX on 7/31/18. He did not give a time frame after which the rash started. It was resolved completely when patient came for 2nd shot on 10/11/18. Pt woke up 10/12/18 with a fever, nausea, diarrhea, vomiting and 1/2 dollar size shingles rash on right glute. Resolved within 10 day with Acyclovir 1 gram TID x 7 days.
your vax gave my wife 32% of her body psoriasis; This spontaneous case was reported by a consumer and describes the occurrence of PSORIASIS (your vax gave my wife 32% of her body psoriasis) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PSORIASIS (your vax gave my wife 32% of her body psoriasis). At the time of the report, PSORIASIS (your vax gave my wife 32% of her body psoriasis) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient experienced 32% of her body with psoriasis, started the day of the shot and hadn't stopped. No concomitant medications were reported. No treatment medications were reported.
Infant vomited once - no fever, no swelling at injection sites - parents believe it was due to vaccinations given
No adverse event; expired dose administered (Expiration Date: Oct 11, 2021 and January 13, 2022); This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired dose administered (Expiration Date: Oct 11, 2021 and January 13, 2022)) and NO ADVERSE EVENT (No adverse event) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049E21A) for COVID-19 prophylaxis.     None allergies to medications, food and other products. Patient never diagnosed with or tested positive for COVID-19. Patient had no acute illness at the time of vaccination and up to one month before. Patient had no chronic or longstanding health conditions.    On 22-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired dose administered (Expiration Date: Oct 11, 2021 and January 13, 2022)). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (expired dose administered (Expiration Date: Oct 11, 2021 and January 13, 2022)) and NO ADVERSE EVENT (No adverse event) outcome was unknown.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered EXPIRED PRODUCT ADMINISTERED (expired dose administered (Expiration Date: Oct 11, 2021 and January 13, 2022)) and NO ADVERSE EVENT (No adverse event) to be not related.    No concomitant information was reported. It was reported that No adverse reaction reported. Patient didn't experience any side effects. The event did not cause the patient to seek medical care. There were no other potential causes. Patient had not experienced similar event in the past. No treatment information was reported.
Right after the shot patient mentioned it hurt. 10 days later she came in and said the pain even extended to her leg and she still couldn't lift her arm fully.
administration of an extra dose of a vaccine, patient received PENTACEL plus an additional dose of DTAP and HIB with no reported adverse event; Initial information received on 24-Jan-2023 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 4 years old male patient where administration of an extra dose of a vaccine, patient received pentacel plus an additional dose of dtap and hib with no reported adverse event while receiving vaccine HIB (prp/t) vaccine [act-hib].  The patient's past medical history, medical treatment(s) and family history were not provided.  Concomitant medications included diphtheria vaccine toxoid, hib vaccine conj (tet tox), pertussis vaccine acellular 5-component, polio vaccine inact 3v (mrc 5), tetanus vaccine toxoid (Pentacel) for Immunisation; diphtheria vaccine toxoid, pertussis vaccine acellular 3-component, tetanus vaccine toxoid (Infanrix) for Immunisation; and Diphtheria vaccine toxoid, pertussis vaccine acellular, tetanus vaccine toxoid (DTAP) for Immunisation.  On 23-Sep-2022, the patient received 0.5 ml QD (daily) dose of suspect hib (prp/t) vaccine Powder and solvent for solution for injection lot number not reported via intramuscular route in the left thigh (strength and expiration date: not provided) as Immunization.  On 23-Sep-2022 the administration of an extra dose of a vaccine, patient received pentacel plus an additional dose of dtap and hib with no reported adverse event (extra dose administered) following the administration of HIB (prp/t) vaccine.  Action taken- Not applicable.  At time of reporting, the outcome was Unknown.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
10 min after receiving flu im and varicella sq child developed muscular rash on the face and chest.
Coughing,  short of breath,  spitting colored spit  and blood, and vomiting
Patient passed out after shot. Came too immediately once try to lay patient with feet elevated. He told us after the fact he does pass out when giving blood
After receiving 3 of 4 forecasted vaccines, client stated, "I'm going to faint".  She then fainted and had tonic like seizure activity during which time her eyes rolled back and she had periods of moaning. The seizure like activity lasted approximately 2 minutes during which time she was non-responsive to verbal commands.  She was breathing and had a pulse during the entire episode.  After she regained consciousness she was asked about previous seizure history and said she had two seizures in the past.  One was related to a hand injury and the other I am unclear about.  She was placed in a supine position during the incident and allowed to remain there for about 10 minutes after regaining consciuosness.  Client then stayed in a sitting position in 'clinic area' for approximately 20 minutes.  She declined transport to an emergency room.  She left the area with her boyfriend.
NAUSEA, CHILLS, SWELLING OF THROAT FRIDAY SLEPT 10HRS, SATURDAY FINE WENT TO MEETING THEN CAME HOME SLEPT 8HRS SORE BACK.
Patient complained of tongue feeling numb intermittently . Given water to drink no difficulty with swallowing.    B/P 122/74  Pulse 83 pox 98% benadryl 25mg po administered 1010. Patient stated not feeling numbness as frequently now. Patient does have anxiety attacks. Pulse and oxygenation remaining stable. Patient able to drink water without difficulty . States feels some numbness at right side of back of neck now only , tongue not swollen.1030 b/p 130/79 pulse 75  Pox 98% From EPIC: Presents to ED with concern for initial numbness at the corners of his mouth about 1 minute after receiving his second Covid vaccine around 10 AM, however symptoms have now resolved.  Patient stated that he felt slightly anxious prior to receiving the second Covid vaccine, but not as anxious as he did after receiving the first vaccine.  Patient stated he received the vaccine around 10 AM and within a minute started feeling numbness at the corners of his lips.  Denies any tongue numbness or other facial numbness or paralysis.  Denies any rash, chest pain, shortness of breath, feeling of throat closing, or difficulty breathing.  Denies any swelling.  Denies any fever, URI symptoms, abdominal pain, vomiting, or diarrhea.  Denies any headache, dizziness, or lightheadedness.  Denies any slurring of speech or facial drooping.  Denies any weakness. Patient received 25 mg of Benadryl at around 10:15 AM and was monitored for total about 30 minutes.  He stated that at about 1/2-hour mark, his symptoms then resolved.  Patient denies any symptoms at this time and states he feels much better and back to his baseline.  Mom stated that while he was being monitored for the half hour, they watched his vital signs which were unremarkable. Of note, mom states the patient has never been formally diagnosed with anxiety however due to he and his sister both having anxiety symptoms, they are going to follow-up with his PCP regarding this.
Pain in the arm of injection(at site and when moving arm), migraine/headache, forehead feels hot, exhaustion, runny nose.
swollen and itchy arm; swollen and itchy arm; This is a spontaneous report from a contactable consumer. A 61-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) dose 2 via an unspecified route of administration, administered in right arm on 28Feb2021 15:00 (at the age of 61-year-old)(Batch/Lot Number: SN6205) as dose 2, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient was not pregnant. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received first dose of bnt162b2 for covid-19 immunisation on 07Feb2021. On 02Mar2021, the patient experienced swollen and itchy arm. The patient did not received treatment for the events. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not been tested for COVID-19. Outcome of events was not recovered.  No follow-up attempts are needed. No further information is expected.
Pt. with adverse reaction to varicella vaccination.  Vitals with mild fever, nontoxic-appearing, no evidence of cellulitis on left deltoid rash.  Rash is nonvesicular and without proximal red streaking.  There are no axillary or cervical or supraclavicular lymph nodes.  Patient has rhinorrhea and a mild cough as well as fatigue and low-grade fever onset 2 weeks post LAD vaccination and varicella.  I suspect patient is developing varicella, started on Valtrex, gave Rx coupon, educated to remain out of work as she works at oncology clinic, for a full 7 days from onset of symptoms which would be tomorrow or until fever free without Tylenol or ibuprofen assistance.  She is to return for further concerns.
developed fever, chills, malaise lasting 6-8 hrs.  Also developed sensitivity  tenderness, swelling in cheeks where cosmetic filler injected in November 2020
I experienced a sore arm a few hours after receiving the shot on 5/10/21. My arm stayed sore for about 24-30 hours. The following evening, I started feeling soreness and tenderness under my left arm pit.
Severe chills, fever, headache, neck pain,  bad taste in mouth, severe  nausea, dry retching and abdominal pain. The severe nausea and abdominal pain continued for 1 1/2 days. I still have some nausea  and intermittent abdominal pain.
Hives, swelling of eyes, diarrhea, vomiting, fatigue. Symptoms peaked at 5 months. Hives still occurring 7 months post injection though less severe than previously.
I was at first having very minor symptoms dry eyes, joint pain and fatigue (huge). I wasn't feeling 100 felt like 90%.